Skip to main content
CTIS.
EU
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
EN — English
BG — Български
CS — Čeština
DA — Dansk
DE — Deutsch
EL — Ελληνικά
ES — Español
ET — Eesti
FI — Suomi
FR — Français
GA — Gaeilge
HR — Hrvatski
HU — Magyar
IT — Italiano
LT — Lietuvių
LV — Latviešu
MT — Malti
NL — Nederlands
PL — Polski
PT — Português
RO — Română
SK — Slovenčina
SL — Slovenščina
SV — Svenska
NO — Norsk
CTIS.
EU
✕
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
Notice
This is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
CTIS.eu
›
Conditions
› Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2 total trials
2 recruiting
Filter these 2 trials by phase, country, sponsor and more.
Open in Search →
A Phase 3 Study of DZD8586 versus Investigator’s Choice in r/r CLL/SLL
Recruiting
2025-522669-32-00
5
2025-12-18
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax P …
Recruiting
2024-517131-52-00
5
2025-11-03
Showing 1–2 of 2 trials